Get 20% lifetime commission for referring investors to digrin.com
here.
DiaMedica Therapeutics Inc. ( DMAC) - Key Metrics
DMAC Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0 | -$0.19 | -$0.15 | -$0.15 |
| 2026Q1 | $0 | -$0.19 | -$0.17 | -$0.17 |
| 2025Q4 | $0 | -$0.19 | -$0.17 | -$0.17 |
| 2025Q3 | $0 | -$0.17 | -$0.13 | -$0.13 |
| 2025Q2 | $0 | -$0.18 | -$0.18 | -$0.18 |
DMAC Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -9.26 |
| 2026Q1 | 0% | -8.91 |
| 2025Q4 | 0% | -11.71 |
| 2025Q3 | 0% | -10.10 |
| 2025Q2 | 0% | -5.42 |
DMAC
Price: $6.62
52 week price:
Earnings Per Share: -0.71 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 67400
Market Capitalization: 357.0 million